TN minister Keerthana breaks silence on London trip menstruation controversy

Tamil Nadu minister Keerthana has finally addressed the public discussion surrounding her recent absence from an official delegation, asserting that personal well-being remains a private matter. The controversy began when political circles and social media platforms started questioning her decision to stay behind during a high-profile government tour to the United Kingdom, leading to various speculations about her role within the cabinet.

The debate intensified following a series of official engagements led by the state leadership abroad, which drew significant media attention back home in Tamil Nadu. Observers and political opponents quickly noted the absence of key cabinet members, prompting widespread discussions regarding internal party dynamics and administrative responsibilities. In recent weeks, the state political landscape has been particularly active, with multiple ministers launching new welfare schemes, addressing energy sector reviews, and managing various public infrastructure initiatives across different districts.

Addressing the inquiries directly, the minister clarified that her absence was entirely due to a necessary medical procedure and subsequent recovery period. Emphasizing the boundaries between public duty and personal life, she stated that health matters should be respected as private affairs rather than politicized for public debate. This explanation aims to put an end to ongoing rumors regarding her commitment to her ministerial portfolio and her working relationship with the state administration.

Moving forward, the minister is expected to resume her full official schedule and oversee upcoming departmental projects across the state. As political activities continue to ramp up in Tamil Nadu with upcoming regional campaigns and administrative rollouts, the government hopes this clarification will redirect public focus back to ongoing governance and developmental initiatives rather than personal controversies.

Follow us on X (Twitter) for more updates.

Leave a Reply

Your email address will not be published. Required fields are marked *